News & Media

This EOM Pharmaceuticals website may contain information, news, and/or press releases, the content of which is accurate or current only as of the date of the particular information, news, press release, or posting. EOM does not update press releases once they have been made public.

Media Kit

News Highlights

Press Release

EOM PHARMACEUTICALS, INC. AND IMMUNOCELLULAR THERAPEUTICS, LTD. ANNOUNCE ENTRY INTO AND CLOSE OF DEFINITIVE MERGER AGREEMENT

January 1, 2022

Montvale, NJ and Los Angeles, CA – December 2, 2021 – EOM Pharmaceuticals, Inc. (“EOM”), a privately held, clinical-stage pharmaceutical company, and ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) (“ImmunoCellular”) today announced that the companies have entered into and closed on a merger agreement pursuant to which the shareholders of EOM are now the majority shareholders of the […]

READ MORE »

Press Releases

January 1, 2022

EOM PHARMACEUTICALS, INC. AND IMMUNOCELLULAR THERAPEUTICS, LTD. ANNOUNCE ENTRY INTO AND CLOSE OF DEFINITIVE MERGER AGREEMENT

DOWNLOAD